Search Results 51-60 of 18408 for IBS

  1. Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients with IBS-D - Mayo Clinic

    About this study. Will Ranolazine improve bowel function and abdominal pain in human subjects with IBS-D? Participation eligibility.

  2. Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS) - Mayo Clinic

    Meet Rome III criteria for IBS. Willing and able to provide written informed consent. If a female of childbearing potential, must be using an acceptable form of ...

  3. Irritable bowel syndrome - Doctors and departments - Mayo Clinic

    Mayo Clinic doctors are conducting clinical trials of new therapies for IBS -related constipation and diarrhea. Researchers in the Enteric Neuroscience ...

  4. Analyzing IBS to Identify Biomarkers and Microbiome Signatures - Mayo Clinic

    About this study. Microbiota from fecal samples from IBS-D patients, in combination with vitamin D supplementation added to our 3-D immunocompetent ...

  5. A Study to Evaluate the Effectiveness, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

    The purpose of this study is to evaluate abdominal pain response to BOS-589 in participants with diarrhea-predominant Irritable Bowel Syndrome (IBS-D) after 4 ...

  6. Irritable bowel syndrome - Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors are conducting clinical trials of new therapies for IBS -related constipation and diarrhea. Researchers in the Enteric ...

  7. Bile Acids, Genetic Control and Ileo-Colonic Mucosal Expression in IBS-D - Mayo Clinic

    Bile Acids, Genetic Control and Ileo-Colonic Mucosal Expression in IBS-D · Overview · Participation eligibility · Participating Mayo Clinic locations · More ...

  8. Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D). - Mayo Clinic

    Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D). · Overview · Participation eligibility.

  9. A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome - Mayo Clinic

    Lyrica is known to have clinical efficacy treating pain disorders including irritable bowel syndrome-related conditions such as fibromyalgia. Participation ...

  10. Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Twice Daily on Nutritional Status in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

    ... Irritable Bowel Syndrome (IBS-D). Print details. Share; Facebook · Twitter ... IBS-D. Participation eligibility. Participant eligibility includes age, gender ...